Endocrine System Disease Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Endocrine System Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes

Type 1 DiabetesEndocrine System DiseasesAutoimmune Diseases+3 more
McGill University106 enrolled1 locationNCT07348432
Recruiting
Not Applicable

Implementation of Support in the Care of Adults Living With Type 1 Diabetes

Metabolic DiseaseType 1 DiabetesEndocrine System Diseases+2 more
McGill University322 enrolled4 locationsNCT06069583
Recruiting
Not Applicable

Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care

Diabetes MellitusMetabolic DiseaseDiabetes Mellitus, Type 1+4 more
Anne-Sophie Brazeau200 enrolled4 locationsNCT05910840
Recruiting
Phase 2

Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury

Central Nervous System DiseasesGenital Diseases, MaleHypogonadism+17 more
North Florida Foundation for Research and Education21 enrolled2 locationsNCT04460872
Recruiting
Not Applicable

Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs

Diabetes MellitusCardiovascular DiseasesDiabetes Mellitus, Type 2+16 more
C5 Biomedical177 enrolled1 locationNCT06674980
Recruiting
Not Applicable

Evaluating a Digital Intervention for Alleviating Diabetes-specific Emotional Distress in Adults Living With T2DM

Metabolic DiseaseDiabetes Mellitus, Type 2Endocrine System Diseases+1 more
Gaia AG250 enrolled1 locationNCT06529965
Recruiting
Not Applicable

In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes

Diabetes MellitusBody WeightMetabolic Disease+9 more
Cornell University60 enrolled1 locationNCT06557317
Recruiting
Phase 1Phase 2

An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D

Diabetes MellitusMetabolic DiseaseDiabetes Mellitus, Type 1+4 more
CRISPR Therapeutics AG40 enrolled2 locationsNCT05565248
Recruiting

OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.

NeoplasmsNeoplasms by SitePancreatic Neoplasm+5 more
OncoSil Medical Limited500 enrolled9 locationsNCT04493632
Recruiting

Spanish Series of Patients Treated With the Radionuclide Lutetium177

Stomach NeoplasmsNeuroendocrine TumorsNeoplasms+15 more
Sociedad Española de Medicina Nuclear e Imagen Molecular5,000 enrolled20 locationsNCT04949282
Recruiting
Not Applicable

RT-CGM in Young Adults at Risk of DKA

Diabetes MellitusMetabolic DiseaseDiabetes Mellitus, Type 1+3 more
Imperial College London20 enrolled1 locationNCT04039763